Fig 4.
Estimates of disease-free survival (± SE) in 540 patients with Philadelphia chromosome–positive childhood acute lymphoblastic leukemia. The patients were classified according to modified Rome–National Cancer Institute criteria as follows: better prognosis (10 years of age or younger with a leukocyte count of < 50,000/μL), intermediate prognosis (intermediate-risk features), and worst prognosis (any age with a leukocyte count of > 100,000/μL). Five-year estimates are shown.